<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We describe the case of a young Lebanese woman with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) and a positive <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> (LAC) who developed right internal jugular vein and sigmoid sinus <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Coagulation studies showed that in addition to the LAC the patient was heterozygous for the factor V (FV) Leiden mutation, and C677T mutation of the <z:chebi fb="0" ids="25297">methylenetetrahydrofolate</z:chebi> reductase gene </plain></SENT>
<SENT sid="2" pm="."><plain>The high prevalence of FV Leiden in the eastern Mediterranean region suggests that we should probably screen our SLE patients in this area, especially those with anticardiolipin antibodies and/or LAC who have no history of <z:mp ids='MP_0005048'>thrombosis</z:mp>, for this and other <z:hpo ids='HP_0100724'>thrombophilia</z:hpo> markers </plain></SENT>
<SENT sid="3" pm="."><plain>The detection of such abnormalities may have major practical consequences for the long-term management of these patients to prevent further thrombotic episodes </plain></SENT>
</text></document>